New York,
New York,
About Amgen Inc.
Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on advances in cellular and molecular biology. The Company operates in human therapeutics. It markets human therapeutic products in the areas of supportive cancer care, nephrology and inflammation. Its principal products include Aranesp (darbepoetin alfa), EPOGEN (Epoetin alfa), Neulasta (pegfilgrastim), NEUPOGEN (Filgrastim) and Enbrel (etanercept). Aranesp and EPOGEN stimulate the production of red blood cells to treat anemia and belong to a class of drugs referred to as erythropoiesis-stimulating agents (ESAs). On January 4, 2008, the Company completed the acquisition of Dompe Biotec, S.p.A.
We Pick Penny Stocks alerts its members on stocks that could generate higher than average returns. These include stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our alerts are well known for producing incredible results in a short amount of time and our members have made outstanding profits of over 100%.
ABOUT We Pick Penny Stocks
WePickPennyStocks.com is a leading stock web site that provides free alerts on stocks that are poised to make big gains. We Pick Penny Stocks also tracks small cap penny stocks that could be on the brink of a massive breakout. To feature a company on our web site please contact us at info@WePickPennyStocks.com
We Pick Penny Stocks is an independent electronic publication that provides information on selected publicly traded companies. We Pick Penny Stocks is not a registered investment advisor or broker-dealer. We Pick Penny Stocks affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.